Editor's Pick
The company analyzed MRD status in samples from a prior failed study, showing a significant benefit from the drug for ctDNA-positive patients.
Doctors and patient advocates supporting pretreatment testing at times challenged FDA and other experts who aren't swayed by available evidence.
Mass General Brigham Becomes Latest US Health System to Adopt Pretreatment DPYD Testing
The change in policy at the health system follows the death of a DPD deficient patient and comes during a period of intense competition among Boston hospitals.
In OurHealth Study, Researchers Seek Genetic Underpinnings of Cardiovascular Disease in South Asians
Premium
Researchers from the Broad Institute, Mass General, Stanford, and elsewhere are investigating why patients with South Asian ancestry are at increased risk.
Parents are suing the defendants for negligent genetic counseling and testing that they allege precluded their ability to avoid having children with Duchenne.